GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Diabetes mellitus, Endocrinology Research Centre, Vol. 23, No. 1 ( 2020-04-21), p. 12-18
    Abstract: BACKGROUND: Diabetic neuroosteoarthropathy (DNOAP, Charcots foot) - is a progressive destructive inflammatory disease of the osteoarticular apparatus of the foot, untimely and inadequate treatment of which can lead to the formation of gross deformities. More often, DNOAP is unilateral, bilateral lesion is relatively rare. It is not always possible to trace the relationship between the debut of DNOAP with trauma and chronic hyperglycemia. There is data demonstrating the role of individual pro-inflammatory factors in the pathogenesis of DNOAP, however, studies combining the evaluation of various metabolic markers of Charcots foot formation are currently extremely poor. AIM: To evaluate the hormonal and metabolic markers of bone formation and resorption in patients with DNOAP and without this diabetic complication. METHODS: A prospective, controlled trial included 70 patients with type 2 diabetes mellitus (37 men and 43 women) who formed 2 groups: group 1 included patients with DNOAP, group 2 was formed by patients with diabetes without foot skeleton damage. All patients underwent a study of 1,25-OH-vitamin D, sclerostin, pro-MMP-1, C-terminal propeptide type 1 collagen (PICP), type 1 collagen, osteocalcin, PTH, 25-OH-vitamin D, beta-cross-slaps. RESULTS: The results of the studies confirmed the presence of vitamin D deficiency in all patients with diabetes mellitus included in the study, revealed the absence of statistically significant differences between the groups in the values of sclerostin, pro-MMP-1; 25-OH-vitamin D, type I collagen, and osteocalcin (p 0.05). However, significant differences were found in the 1.25-OH vitamin D levels: patients with DNOAP presented the lower rates of 1,25-OH-vitamin D in comparison to control group (p 0.05). Beta-cross and PICP levels were significantly higher in DNOAP patients as well (p 0.05). Those findings show the more severe collagen degradation in patients with DNOAP and can be the genetically predisposed cause of DNOAP development. Though further studies are needed. CONCLUSION: In patients with DNOAP a decrease in 1,25-OH-vitamin D levels was found, as well as the alteration of the synthesis and destruction of collagen (beta-cross-slaps and PICP) compared to patients with diabetes mellitus without osteoarticular disorders.
    Type of Medium: Online Resource
    ISSN: 2072-0378 , 2072-0351
    URL: Issue
    Language: Unknown
    Publisher: Endocrinology Research Centre
    Publication Date: 2020
    detail.hit.zdb_id: 2820710-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Obesity and metabolism, Endocrinology Research Centre, Vol. 14, No. 4 ( 2017-12-27), p. 67-72
    Abstract: Aim. To estimate the trabecular bone score (TBS) for evaluation of fracture probability in order to make decisions about starting osteoporosis treatment in patients with type 2 diabetes mellitus (T2DM). Materials and methods. We obtained the bone mineral density (BMD) and trabecular bone score (TBS) using dual energy X-ray absorptiometry (iDXA) in patients with T2DM (with and without a history of osteoporotic fractures) versus the control group. Before and after TBS measurements we assessed the ten-year probability of fracture using the Fracture Risk Assessment Tool (FRAX). Results. We enrolled 48 patients with T2DM, including 17 with a history of low-traumatic fracture, 31 patients without fractures and 29 subjects of a control group. BMD was higher in patients with T2DM compared to the control group at L1L4 (mean T-score 0.44, 95% CI -3.2 4.9 vs mean T-score 0.33, 95% CI -2.9 3.0 in a control group p=0.052) and Total Hip (mean T-score 0.51, 95% CI -2.1 3.0 vs mean T-score -0.03, 95% CI -1.4 1.2 in a control group p=0,025). The TBS and 10-year probability of fracture (FRAX) was not different in patients with T2DM versus the control group. However, when the TBS was entered as an additional risk factor, the 10-year probability of fracture became higher in patients with T2DM (10-year probability of fracture in T2DM- 8.68, 95% CI 0.3-25.0 versus 6.68, 95% CI 0.415.0 in control group, p=0.04). Among patients with diabetes with and without fractures the FRAX score was higher in subjects with fractures, but no difference was found in regards to BMD or TBS. Entering BMD and TBS values into the FRAX tool in subjects with diabetes and fractures decreased the FRAX score. However, patients with low-traumatic fractures should be treated for osteoporosis without a BMD, TBS or FRAX assessment. Conclusion. TBS improves the results of FRAX assessment in patients with T2DM and should be entered while evaluating FRAX in patients with T2DM. However, additional research is needed to develop a more sensitive tool to evaluate fracture risk in patients with T2DM.
    Type of Medium: Online Resource
    ISSN: 2306-5524 , 2071-8713
    Language: Unknown
    Publisher: Endocrinology Research Centre
    Publication Date: 2017
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Federal Scientific Center for Hygiene F.F.Erisman ; 2021
    In:  Hygiene and sanitation Vol. 100, No. 3 ( 2021-04-16), p. 234-239
    In: Hygiene and sanitation, Federal Scientific Center for Hygiene F.F.Erisman, Vol. 100, No. 3 ( 2021-04-16), p. 234-239
    Abstract: Introduction. The microbiota of the gastrointestinal tract (GIT) plays an essential role in maintaining human health. Many factors, including industrial pollutions with biotechnological strains of microbes, can affect the normal balance of intestinal microbiota. The biotechnological industry nowadays produces a wide range of products for medical and veterinary use, agriculture, food, chemical industries, etc. To develop hygienic standards that regulate the possible adverse effect of biotechnological strains of microorganisms on workers’ health, the intestinal microflora of rats in the experiment can be studied. The data obtained were used as the basic concept in elaborating state sanitary standards for limitations of the concentrations of biotechnological strains of microorganisms in the ambient air of the working area and settlements’ atmosphere. Materials and methods. We have tested 52 strains of microorganisms applied in biotechnology as producers of a variety of biological substances. They included members of different taxonomic groups: gram-positive and gram-negative bacteria, actinomycetes, molds, and yeasts. The experiments were carried out on conventional male and female white rats (290-320 g, body weight). Each test and control group of animals included eight animals. The strains of microorganisms mentioned above were given to animals by inhalation of minimal effective doses of microbes in the concentrations of 103-108 CFU/m3 during one month. To demonstrate possible adverse effects to gut microflora, the routine bacteriological examination of animal feces was performed. To do this, after the priming, the 10-fold dilutions of animal feces in sterile saline were inoculated onto a set of general-purpose and selective culture media for Enterobacteriaceae members, staphylococci, enterococci, clostridia, bifidobacteria, lactobacilli, and fungi, with subsequent identification of the genus of the isolated microorganism. After that, the concentrations of microorganisms were calculated and measured in lg of CFU/g of feces. The Institutional Ethical Committee of Animal Care and Use of the Pirogov Russian National Research Medical University approved all procedures involving animals. The results of experiments were analyzed with a simple t-test using Statistica (v.6.0, Stat Soft, USA) and Microsoft Office Excel 2007. Results were considered statistically significant when p 〈 0.05. Results. The most notable changes in the composition of the intestinal microbiota were observed after inhaling of yeasts of genus Candida at the level of 103-104 CFU/m3 and in cases of exposure to molds (Aspergillus awamori, Penicillium funiculosum, and Tolypocladium cylindrosporum) in the concentration of 2•104 CFU/m3, and gram-negative bacteria of the genus Alcaligenes and genus Pseudomonas at 5•105 CFU/m3. We observed a dramatic decrease of Escherichia coli and the increase of gram-positive bacteria (staphylococci, enterococci). For some genera of biotechnological strains, a significant decline in the content of lactobacilli was also shown. On the other hand, Rhodococcus did not cause any disturbances even at high concentrations in the ambient air. Conclusion. The obtained data can be used to develop biosafety and hygienic standards for industrial microbes to help decrease or minimize the occupational risk of infection or undesirable allergic effect when working with biotechnological strains of microbes in the ambient air of residential areas.
    Type of Medium: Online Resource
    ISSN: 2412-0650 , 0016-9900
    URL: Issue
    Language: Unknown
    Publisher: Federal Scientific Center for Hygiene F.F.Erisman
    Publication Date: 2021
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Diabetes mellitus, Endocrinology Research Centre, Vol. 22, No. 5 ( 2020-01-17), p. 405-416
    Abstract: BACKGROUND: Normoglycaemia in patients with diabetes mellitus type 1 (T1DM) after simultaneous pancreas-kidney transplantation (SPKT) is very interesting in regards to chronic kidney disease (CKD) complications dynamics depending of posttransplantation period and possible targets of potential treatment from the point of view metabolic memory AIM: To evaluate the relationship between oxidative stress indicators and advanced glycation end products and complications of end-stage renal disease (ESRD) in patients with T1DM аnd a long-term history of diabetes decompensation, who reached stable euglycemia after SPKT. MATERIALS AND METHODS: The study included 20 patients with compensation of carbohydrate metabolism after SPKT performed from November 2011 to September 2018. Assessment included examination of complications of ESRD (arterial hypertension, dyslipidemia, anemia, mineral and bone disorder) and analysis of "metabolic memory" markers: 3-nitrothyrosine (3-NT), superoxide dismutase (SOD), advanced glycation end products (AGE) and AGE receptor (RAGE). We performed follow-up examination of patients included in the early postoperative period (1st day/week) in 6-12 months after SPKT. RESULTS: All patients with DM1 duration for 22 [19; 28] years, diabetic nephropathy (DN) 8 [6; 14] years and duration of renal replacement therapy (dialysis) for 3 [1.5; 4] years reached euglycemia (HbA1c 5,5 [5,1; 5,8] %; С-peptide 3,2 [2,45; 3,63] ng/ml) after 6 month of surgical treatment. Despite of stable graft function (estimated glomerular filtration rate (eGFR) CKD-EPI 84 [69; 95] ml/min/1.73m2) 35% of patients still needed antihypertensive therapy, 40% needed treatment with recombinant human erythropoietin (RHuEPO) and 15% ferrotherapy. With vitamin D deficiency, observed in 80% of cases (13.3 [9.3; 18.5] ng/ml), 55% of patients had secondary hyperparathyroidism, 45% osteoporosis. The results of the correlation analysis revealed the association of the state of ESRD target organs with the studied "metabolic memory" markers: oxidative stress and AGE-RAGE system. CONCLUSIONS: SPKT as the way to achieve compensation of carbohydrate metabolism and uremia does not provide regress of diabetes and complications of ESRD. Analysis of "metabolic memory" markers indicate their direct contribution to the persistence of metabolic consequences of diabetic nephropathy (DN). Found trends need more long-lasting observation and enlargement of study groups.
    Type of Medium: Online Resource
    ISSN: 2072-0378 , 2072-0351
    Language: Unknown
    Publisher: Endocrinology Research Centre
    Publication Date: 2020
    detail.hit.zdb_id: 2820710-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Osteoporosis and Bone Diseases, Endocrinology Research Centre, Vol. 21, No. 3 ( 2019-04-08), p. 4-14
    Abstract: BACKGROUND: Patients with endogenous hypercortisolism have reduced bone mineral density (BMD) and trabecular bone score (TBS) that are the causes of secondary osteoporosis and low-traumatic fractures. It is well known that radical treatment (neurosurgery or radiosurgery) of Cushing’s disease leads to a decline of cortisol levels in all body fluids to normal values. However, it is still uncertain whether bone tissue structure, and particularly its microarchitecture, does recover in remission of the disease. AIMS: To evaluate an influence of hormone activity (presence or absence of remission) in patients with Cushing's disease on changes of bone structure measurements in accordance with DXA values (TBS, BMD, T- and Z-scores), as well as significance of such changes in 12 and 24 months after neurosurgical treatment. MATERIALS AND METHODS: In patients with confirmed active Cushing's disease (ACTH-producing pituitary adenoma) (n = 44) and in control group of healthy volunteers (n = 40), BMD in lumbar spine (L1-L4) and simultaneously TBS, in cut-off points before neurosurgical treatment (in both groups) and in 12 and 24 months after it (only in patients), were assessed. We diagnosed presence or absence of disease remission at cut-offs. All measurements were performed using a GE iDXA device (GE Healthcare Lunar, Madison, Wisconsin, USA). The TBS was calculated simultaneously from taken BMD scans, blinded to clinical outcome using TBS iNsight software v2.1 (Medimaps, Merignac, France). The activity of Cushing’s disease was evaluated using late-night salivary cortisol (LNSC, at 23:00). To determine the differences in DXA and TBS values before and after neurosurgical intervention depending on remission occurrence, covariate analysis (ANCOVA) was applied. RESULTS: There were found significant changes in TBS, BMD and T-score values in 12 months after neurosurgical treatment associated with presence or absence of disease remission (p = 0.039, 0.046 and 0.048, respectively). No differences in Z-score as well as in all measurements in 24 months, that might be associated with remission occurrence, were revealed. The gain in all DXA measurements (including TBS) during 24 months of observation period was statistically significant when analyzing data using Student’s paired t-test. However, the values corresponding to the age references had not been achieved for the specified time interval. CONCLUSIONS: Patients with Cushing’s disease have lower TBS values. In remission conditions TBS is getting significantly higher. The increase in BMD and TBS occurs during 24 months after achieving remission of Cushing’s disease but doesn’t lead to a full restoration of normal bone mass and microstructure throughout observation period of 24 months.
    Type of Medium: Online Resource
    ISSN: 2311-0716 , 2072-2680
    URL: Issue
    Language: Unknown
    Publisher: Endocrinology Research Centre
    Publication Date: 2019
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Federal Scientific Center for Hygiene F.F.Erisman ; 2023
    In:  Hygiene and sanitation Vol. 102, No. 2 ( 2023-03-25), p. 135-140
    In: Hygiene and sanitation, Federal Scientific Center for Hygiene F.F.Erisman, Vol. 102, No. 2 ( 2023-03-25), p. 135-140
    Abstract: Introduction. The use of microorganisms in biotechnological enterprises, agriculture, and forestry can be accompanied by microbial contamination of the environment and have an adverse effect on the human health. The purpose of the research is to develop and put into practice quantitative criteria for the pathogenicity of biotechnological microorganisms as the first stage in assessing their safety. Materials and methods. Lethal dose (LD50) and “threshold” (Limbact) doses, dissemination in internal organs, toxigenicity, and “pathogenicity enzymes” of thirty-three strains of saprophytic, opportunistic and pathogenic bacteria, 250 strains of 10 genera proposed for use in biotechnology, and 11 strains already used as active biopreparation substances were investigated. Results. Based on the criteria for primary sanitary and hygienic assessment, microorganisms were selected into three groups: strains recommended for industrial use; strains at risk of application; strains not recommended for use. Among the studied 250 strains of microorganisms proposed for use in biotechnology, 38.9% did not have pathogenic properties and can be used, 41.0% are conditionally pathogenic and are at risk of use, and 20.1% are not recommended for use in biotechnology due to the presence of pathogenic properties. A study of the pathogenic properties of 11 strains of bacteria that are the part of modern biological products showed that they belong to non-pathogenic microorganisms. Limitations. The development and testing of the criteria for the primary sanitary and hygienic assessment of microorganisms proposed for biotechnology were carried out on a large material (more than 250 strains) with a single exposure to high doses, which did not allow us to assess the specific effects of exposure to strains during long-term exposure and may be the subject of further research. Conclusion. The criteria for the primary sanitary and hygienic assessment of microorganisms proposed for use in biotechnologies include average lethal and “threshold” doses dissemination in internal organs, toxigenicity and activity of “pathogenicity enzymes”. All planned for use in biotechnology microorganisms should be examined for possible pathogenic properties. Biological products used in real time in the national economy contain only saprophytic microorganisms as an active substance. The problem of biosafety should be solved in the direction of studying the specific effect of microorganisms and biological products on the immune system influence and the state of the microcenosis of the body.
    Type of Medium: Online Resource
    ISSN: 2412-0650 , 0016-9900
    URL: Issue
    Language: Unknown
    Publisher: Federal Scientific Center for Hygiene F.F.Erisman
    Publication Date: 2023
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: History of Medicine/ru, The Classical Studies Foundation, Vol. 5, No. 1 ( 2018), p. 28-34
    Type of Medium: Online Resource
    ISSN: 2500-2910 , 2409-5834
    Uniform Title: Санитарно-микробиологическое направление исследований на кафедре гигиены РНИМУ имени Н.И. Пирогова: история и современность
    Language: Unknown
    Publisher: The Classical Studies Foundation
    Publication Date: 2018
    detail.hit.zdb_id: 2842644-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: Osteoporosis and Bone Diseases, Endocrinology Research Centre, Vol. 22, No. 4 ( 2020-08-16), p. 4-11
    Abstract: Aim. To estimate the trabecular bone score (TBS) for evaluation of fracture probability in order to make decisions about starting osteoporosis treatment in patients with type 2 diabetes mellitus (T2DM). Materials and methods. We obtained the bone mineral density (BMD) and trabecular bone score (TBS) using dual energy X-ray absorptiometry (iDXA) in patients with T2DM (with and without a history of osteoporotic fractures) versus the control group. Before and after TBS measurements we assessed the ten-year probability of fracture using the Fracture Risk Assessment Tool (FRAX). Results. We enrolled 48 patients with T2DM, including 17 with a history of low-traumatic fracture, 31 patients without fractures and 29 subjects of a control group. BMD was higher in patients with T2DM compared to the control group at L1L4 (mean T-score 0.44, 95% CI -3.2 4.9 vs mean T-score 0.33, 95% CI -2.9 3.0 in a control group p=0.052) and Total Hip (mean T-score 0.51, 95% CI -2.1 3.0 vs mean T-score -0.03, 95% CI -1.4 1.2 in a control group p=0,025). The TBS and 10-year probability of fracture (FRAX) was not different in patients with T2DM versus the control group. However, when the TBS was entered as an additional risk factor, the 10-year probability of fracture became higher in patients with T2DM (10-year probability of fracture in T2DM- 8.68, 95% CI 0.3-25.0 versus 6.68, 95% CI 0.415.0 in control group, p=0.04). Among patients with diabetes with and without fractures the FRAX score was higher in subjects with fractures, but no difference was found in regards to BMD or TBS. Entering BMD and TBS values into the FRAX tool in subjects with diabetes and fractures decreased the FRAX score. However, patients with low-traumatic fractures should be treated for osteoporosis without a BMD, TBS or FRAX assessment. Conclusion. TBS improves the results of FRAX assessment in patients with T2DM and should be entered while evaluating FRAX in patients with T2DM. However, additional research is needed to develop a more sensitive tool to evaluate fracture risk in patients with T2DM.
    Type of Medium: Online Resource
    ISSN: 2311-0716 , 2072-2680
    URL: Issue
    Language: Unknown
    Publisher: Endocrinology Research Centre
    Publication Date: 2020
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Materials Science Forum, Trans Tech Publications, Ltd., Vol. 1037 ( 2021-07-06), p. 167-173
    Abstract: The post-sintering properties of walling high-calcium ceramics based on clay-containing raw materials in low-temperature roasting depend on the chemical-mineralogical composition of clay with different contents of iron, calcium-containing and alkaline oxides that contribute to the formation of new crystalline phases, which provide for the production of low-density ceramic material with high-strength properties.
    Type of Medium: Online Resource
    ISSN: 1662-9752
    URL: Issue
    Language: Unknown
    Publisher: Trans Tech Publications, Ltd.
    Publication Date: 2021
    detail.hit.zdb_id: 2047372-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Frontiers in Immunology, Frontiers Media SA, Vol. 11 ( 2020-8-6)
    Type of Medium: Online Resource
    ISSN: 1664-3224
    Language: Unknown
    Publisher: Frontiers Media SA
    Publication Date: 2020
    detail.hit.zdb_id: 2606827-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...